NCT01950637View on ClinicalTrials.gov

GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
BEHAVIORAL

No treatment given

Completion of 90-item online questionnaire.

BEHAVIORAL

survey

Completion of 58-item online questionnarie.

Trial Locations (6)

2300

Novo Nordisk Investigational Site, Copenhagen S

55127

Novo Nordisk Investigational Site, Mainz

1000005

Novo Nordisk Investigational Site, Tokyo

08540

Novo Nordisk Investigational Site, Princeton

L4W 4XI

Novo Nordisk Investigational Site, Mississauga

RH11 9RT

Novo Nordisk Investigational Site, Crawley

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01950637 - GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter